纳米技术是否过于宽泛而难以应用？ - Suppr

Suppr

超能文献

Is nanotechnology too broad to practise?

作者信息

Drezek Rebekah A, Tour James M

机构信息

Rice University, 6100 Main, Houston, Texas 77005-1827, USA.

出版信息

Nat Nanotechnol. 2010 Mar;5(3):168-9. doi: 10.1038/nnano.2010.37.

DOI:10.1038/nnano.2010.37

PMID:20203616

Abstract

摘要

相似文献

Is nanotechnology too broad to practise?

Nat Nanotechnol. 2010 Mar;5(3):168-9. doi: 10.1038/nnano.2010.37.

Nanotechnology. EPA ponders voluntary nanotechnology regulations.

Science. 2005 Jul 1;309(5731):36. doi: 10.1126/science.309.5731.36b.

The US must help set international standards for nanotechnology.

Nat Nanotechnol. 2008 Nov;3(11):635-6. doi: 10.1038/nnano.2008.323.

The continuing uncertainty of nano risks and regulations.

Environ Sci Technol. 2008 Nov 1;42(21):7733. doi: 10.1021/es802396x.

Too small to overlook.

Nature. 2009 Jul 9;460(7252):174. doi: 10.1038/460174a.

International standards for risk management in nanotechnology.

Nat Nanotechnol. 2009 Apr;4(4):205; author reply 205-6. doi: 10.1038/nnano.2009.25.

Nanotechnology: safety issues.

Clin Lab Sci. 2010 Spring;23(2):122-6.

Nanotechnology in healthcare: are existing laws adequate?

Eur J Health Law. 2007 Nov;14(3):261-72. doi: 10.1163/092902707x240611.

Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.

J Nanosci Nanotechnol. 2010 Dec;10(12):8646-57. doi: 10.1166/jnn.2010.2493.

Don't define nanomaterials.

Nature. 2011 Jul 6;475(7354):31. doi: 10.1038/475031a.

引用本文的文献

Redox-active nanomaterials for nanomedicine applications.

Nanoscale. 2017 Oct 19;9(40):15226-15251. doi: 10.1039/c7nr05429g.

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.

Sci Rep. 2016 Sep 22;6:33808. doi: 10.1038/srep33808.

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.

PLoS One. 2016 Feb 1;11(2):e0148139. doi: 10.1371/journal.pone.0148139. eCollection 2016.

The problem of regulating sophisticated materials.

Nat Mater. 2011 Jul 22;10(8):554-7. doi: 10.1038/nmat3085.

Management of nanomaterials safety in research environment.

Part Fibre Toxicol. 2010 Dec 10;7:40. doi: 10.1186/1743-8977-7-40.

Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors noncovalently loaded with unmodified Paclitaxel.

ACS Nano. 2010 Aug 24;4(8):4621-36. doi: 10.1021/nn100975c.

本文引用的文献

Too small to overlook.

Nature. 2009 Jul 9;460(7252):174. doi: 10.1038/460174a.

Late lessons from early warnings for nanotechnology.

Nat Nanotechnol. 2008 Aug;3(8):444-7. doi: 10.1038/nnano.2008.198. Epub 2008 Jul 20.

Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.

Nat Nanotechnol. 2008 Jul;3(7):423-8. doi: 10.1038/nnano.2008.111. Epub 2008 May 20.

Cytotoxicity of nanoparticles.

Small. 2008 Jan;4(1):26-49. doi: 10.1002/smll.200700595.

Nanotechnology safety concerns revisited.

Toxicol Sci. 2008 Jan;101(1):4-21. doi: 10.1093/toxsci/kfm169. Epub 2007 Jun 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Is nanotechnology too broad to practise?

Nat Nanotechnol. 2010 Mar;5(3):168-9. doi: 10.1038/nnano.2010.37.

Nanotechnology. EPA ponders voluntary nanotechnology regulations.

Science. 2005 Jul 1;309(5731):36. doi: 10.1126/science.309.5731.36b.

The US must help set international standards for nanotechnology.

Nat Nanotechnol. 2008 Nov;3(11):635-6. doi: 10.1038/nnano.2008.323.

The continuing uncertainty of nano risks and regulations.

Environ Sci Technol. 2008 Nov 1;42(21):7733. doi: 10.1021/es802396x.

Too small to overlook.

Nature. 2009 Jul 9;460(7252):174. doi: 10.1038/460174a.

International standards for risk management in nanotechnology.

Nat Nanotechnol. 2009 Apr;4(4):205; author reply 205-6. doi: 10.1038/nnano.2009.25.

Nanotechnology: safety issues.

Clin Lab Sci. 2010 Spring;23(2):122-6.

Nanotechnology in healthcare: are existing laws adequate?

Eur J Health Law. 2007 Nov;14(3):261-72. doi: 10.1163/092902707x240611.

Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.

J Nanosci Nanotechnol. 2010 Dec;10(12):8646-57. doi: 10.1166/jnn.2010.2493.

Don't define nanomaterials.

Nature. 2011 Jul 6;475(7354):31. doi: 10.1038/475031a.

引用本文的文献

Redox-active nanomaterials for nanomedicine applications.

Nanoscale. 2017 Oct 19;9(40):15226-15251. doi: 10.1039/c7nr05429g.

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.

Sci Rep. 2016 Sep 22;6:33808. doi: 10.1038/srep33808.

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.

PLoS One. 2016 Feb 1;11(2):e0148139. doi: 10.1371/journal.pone.0148139. eCollection 2016.

The problem of regulating sophisticated materials.

Nat Mater. 2011 Jul 22;10(8):554-7. doi: 10.1038/nmat3085.

Management of nanomaterials safety in research environment.

Part Fibre Toxicol. 2010 Dec 10;7:40. doi: 10.1186/1743-8977-7-40.

Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors noncovalently loaded with unmodified Paclitaxel.

ACS Nano. 2010 Aug 24;4(8):4621-36. doi: 10.1021/nn100975c.

本文引用的文献

Too small to overlook.

Nature. 2009 Jul 9;460(7252):174. doi: 10.1038/460174a.

Late lessons from early warnings for nanotechnology.

Nat Nanotechnol. 2008 Aug;3(8):444-7. doi: 10.1038/nnano.2008.198. Epub 2008 Jul 20.

Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.

Nat Nanotechnol. 2008 Jul;3(7):423-8. doi: 10.1038/nnano.2008.111. Epub 2008 May 20.

Cytotoxicity of nanoparticles.

Small. 2008 Jan;4(1):26-49. doi: 10.1002/smll.200700595.

Nanotechnology safety concerns revisited.

Toxicol Sci. 2008 Jan;101(1):4-21. doi: 10.1093/toxsci/kfm169. Epub 2007 Jun 30.